The Coburn Amendment to the Agricultural Appropriations Bill, which would limit the FDA’s ability to continue research on mifepristone (formerly known as RU486), is expected to be introduced this week. Mifepristone is an early abortion pill that has been available to women outside of the U.S. for 12 years. In addition to its uses in terminating a pregnancy at a very early stage extremely safely, mifepristone is also a possible treatment for diseases and conditions that particularly effect women such as brain tumors (meningioma), ovarian cancer and fibroid tumors.
Click Here to Tell Your Representatives Not to Let Anti-Abortion Politics Interfere with Scientific Research, the FDA, and Women’s Healthcare.
